Phenomex Inc Revenue Growth Rates (CELL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Phenomex Inc   (NASDAQ: CELL)
 

CELL's Revenue Growth by Quarter and Year

Phenomex Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELL Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June 14.04
1st Quarter March 18.52
FY 32.56





CELL Revenue second quarter 2023 Y/Y Growth Comment
Phenomex Inc reported fall in Revenue in the second quarter 2023 by -26.67% to $ 14.04 millions, from the same quarter in 2022.
This represents worst decline in recent Company history.

Looking into second quarter 2023 results within Laboratory Analytical Instruments industry 23 other companies have achieved higher Revenue growth. While Phenomex Inc ' s Revenue drop of -26.67% ranks overall at the positon no. 3538 in the second quarter 2023.


CELL Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - -23.07 % 6.62 % 30.87 %
3rd Quarter September - -12.01 % 33.55 % 16.21 %
2nd Quarter June -26.67 % -0.52 % 82.12 % -10.12 %
1st Quarter March -8.36 % 8.48 % 35.2 % 9.02 %
FY   - -7.95 % 32.78 % -

Financial Statements
Phenomex Inc 's second quarter 2023 Revenue $ 14.04 millions CELL's Income Statement
Phenomex Inc 's second quarter 2022 Revenue $ 19.15 millions Quarterly CELL's Income Statement


CELL Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - -16.64 % -4.65 % 19.44 %
3rd Quarter September - 11.75 % 26.34 % 72.28 %
2nd Quarter June -24.17 % -5.24 % 3.33 % -23.29 %
1st Quarter March 3.81 % -12.85 % -14.34 % -17.09 %
FY (Year on Year)   - -7.95 % 32.78 % -


Back to CELL Growth rate Comparisons >> Back to CELL Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #24
Healthcare Sector #536
Overall #3538

Revenue Y/Y Growth Statistics
High Average Low
82.14 % 6.7 % -26.67 %
(Jun 30 2021)   (Jun 30 2023)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #24
Healthcare Sector #536
Overall #3538
Revenue Y/Y Growth Statistics
High Average Low
82.14 % 6.7 % -26.67 %
(Jun 30 2021)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Phenomex Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
72.28 % 5.4 % -24.16 %
(Sep 30 2020)  


CELL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Phenomex Inc disclosed fall in Revenue from the first quarter by -24.17% to $ 14.04 millions, from $ 18.52 millions achived in the previous reporting period.

But that's not important problem, as Phenomex Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Phenomex Inc 's Revenue growth quarter on quarter, overall rank is 3859.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #597
Overall #3859
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #25
Healthcare Sector #597
Overall #3859
Revenue Q/Q Growth Statistics
High Average Low
72.28 % 5.4 % -24.16 %
(Sep 30 2020)  


CELL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Phenomex Inc disclosed fall in Revenue from the first quarter by -24.17% to $ 14.04 millions, from $ 18.52 millions achived in the previous reporting period.

But that's not important problem, as Phenomex Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Phenomex Inc 's Revenue growth quarter on quarter, overall rank is 3859.


Phenomex Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 71.80 $ 76.91 $ 78.60 $ 83.94 $ 86.87
Y / Y Revenue Growth (TTM) -17.35 % -11.57 % -7.96 % -0.01 % 11.6 %
Year on Year Revenue Growth Overall Ranking # 148 # 76 # 0 # 0 # 81
Seqeuential Revenue Change (TTM) -6.64 % -2.15 % -6.37 % -3.37 % -0.11 %
Seq. Revenue Growth (TTM) Overall Ranking # 2543 # 2202 # 0 # 0 # 0


Cumulative Revenue growth Comment
Phenomex Inc 's cumulative 12 months Revenue continue to fall, but on the faster rate at -17.35% year on year, at Jun 30 2023 compare to the -11.57% decrease at Mar 31 2023. If the Phenomex Inc 's fiscal year would end at Jun 30 2023, annual Revenue would be $72 millions.

In the Healthcare sector 44 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 76 to 148.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 45
Overall # 148

Revenue TTM Y/Y Growth Statistics
High Average Low
366.86 %
 116.53 %
-17.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 383
S&P 500 # 2543
Cumulative Revenue growth Comment
Phenomex Inc 's cumulative 12 months Revenue continue to fall, but on the faster rate at -17.35% year on year, at Jun 30 2023 compare to the -11.57% decrease at Mar 31 2023. If the Phenomex Inc 's fiscal year would end at Jun 30 2023, annual Revenue would be $72 millions.

In the Healthcare sector 44 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 76 to 148.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 16
Healthcare Sector # 45
Overall # 148

Revenue TTM Y/Y Growth Statistics
High Average Low
366.86 %
116.53 %
-17.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 383
S&P 500 # 2543




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CELL's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Fortrea Holdings Inc -0.01%$ -0.013 millions
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Procyon Corporation-0.59%$ -0.589 millions
Amedisys Inc-0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc -1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Procaps Group S a -2.10%$ -2.102 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Oncology inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
Nrc Health-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Omniab Inc -3.51%$ -3.514 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Vireo Growth Inc.-4.24%$ -4.237 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions


About Phenomex Inc Revenue Growth Rates (CELL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Phenomex Inc (CIK 1689657).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001689657-23-000032
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Phenomex Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.